Home Cart 0 Sign in  
X

[ CAS No. 21739-93-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 21739-93-5
Chemical Structure| 21739-93-5
Chemical Structure| 21739-93-5
Structure of 21739-93-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 21739-93-5 ]

Related Doc. of [ 21739-93-5 ]

Alternatived Products of [ 21739-93-5 ]

Product Details of [ 21739-93-5 ]

CAS No. :21739-93-5 MDL No. :MFCD00013982
Formula : C7H4BrClO2 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 235.46 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 21739-93-5 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.11
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.69 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.75
Log Po/w (XLOGP3) : 2.88
Log Po/w (WLOGP) : 2.8
Log Po/w (MLOGP) : 2.94
Log Po/w (SILICOS-IT) : 2.54
Consensus Log Po/w : 2.58

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.45
Solubility : 0.0832 mg/ml ; 0.000353 mol/l
Class : Soluble
Log S (Ali) : -3.32
Solubility : 0.112 mg/ml ; 0.000475 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.25
Solubility : 0.134 mg/ml ; 0.000568 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.43

Safety of [ 21739-93-5 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 21739-93-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 21739-93-5 ]
  • Downstream synthetic route of [ 21739-93-5 ]

[ 21739-93-5 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 21739-93-5 ]
  • [ 124-42-5 ]
  • [ 7142-09-8 ]
YieldReaction ConditionsOperation in experiment
81% With copper(l) iodide; TPGS-450-M; caesium carbonate In water at 20℃; for 12 h; Inert atmosphere; Green chemistry General procedure: A two-neck round bottom flask was charged with a magnetic stirrer, evacuated and backfilled with nitrogen. Substituted 2-halobenzoic acid (1, 0.5 mmol) and amidine hydrochloride (2, 0.75 mmol) or bis(guanidine) sulphate (2, 0.38 mmol) in 2 wt percent TPGS-750-M (3 mL) were added under nitrogen atmosphere. After a 10-min stirring, Cs2CO3 (1 mmol, 326 mg) was added to the flask. 15 min later, CuI (0.1 mmol, 19 mg) was added to the flask. The mixture was allowed to stir under nitrogen atmosphere at the shown temperature for 12 h (see Table 3 in text). After completion of the reaction, the mixture was extracted with EtOAc (1 mL), and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using petroleum ether/ethyl acetate (3:1 to 1:1) as eluent to provide the desired product.
Reference: [1] RSC Advances, 2014, vol. 4, # 91, p. 50285 - 50294
[2] Angewandte Chemie - International Edition, 2009, vol. 48, # 2, p. 348 - 351
[3] Tetrahedron, 2015, vol. 71, # 29, p. 4853 - 4858
[4] Applied Organometallic Chemistry, 2014, vol. 28, # 9, p. 661 - 665
  • 2
  • [ 21739-93-5 ]
  • [ 635-21-2 ]
Reference: [1] Journal of Organic Chemistry, 2010, vol. 75, # 10, p. 3311 - 3316
  • 3
  • [ 21739-93-5 ]
  • [ 27007-53-0 ]
YieldReaction ConditionsOperation in experiment
92% With hydrogenchloride In methanol Step 1.
methyl 2-bromo-5-chlorobenzoate
Into a stirred solution of 2-bromo-5-chlorobenzoic acid (11 g, 46.7 mmol, HPLC RT=2.99 min) in methanol (250 mL) at 0° C. was bubbled HCl gas.
The reaction was allowed to warm to room temperature and stirred overnight.
The reaction mixture was concentrated in vacuo to give an orange oil, which was purified by flash chromatography using hexanes as eluant to give methyl 2-bromo-5-chlorobenzoate as a colorless oil (10.7 g, 92percent yield). TLC Rf=0.6 (5percent EtOAc-hexanes); HPLC RT=3.48 min (Method A); 1H NMR (CDl3, 400 MHz) 7.78 ppm (d, 1H, J=2.6 Hz); 7.59 ppm (d, 1H, J=12.81 Hz);7.30 ppm (dd, 1H, J=8.6, 2.5 Hz); 3.94 ppm (s, 3H).
92% With hydrogenchloride In methanol Step 1.
methyl 2-bromo-5-chlorobenzoate
Into a stirred solution of 2-bromo-5-chlorobenzoic acid (11 g, 46.7 mmol, HPLC RT=2.99 min) in methanol (250 mL) at 0° C. was bubbled HCl gas.
The reaction was allowed to warm to room temperature and stirred overnight.
The reaction mixture was concentrated in vacuo to give an orange oil, which was purified by flash chromatography using hexanes as eluant to give methyl 2-bromo-5-chlorobenzoate as a colorless oil (10.7 g, 92percent yield). TLC Rf=0.6 (5percent EtOAc-hexanes); HPLC RT=3.48 min (Method A); 1H NMR (CDCl3, 400 MHz) 7.78 ppm (d, 1H, J=2.6 Hz); 7.59 ppm (d, 1H, J=12.81 Hz);7.30 ppm (dd, 1H, J=8.6, 2.5 Hz); 3.94 ppm (s, 3H).
92% With hydrogenchloride In methanol Step 1.
Into a stirred solution of 2-bromo-5-chlorobenzoic acid (11 g, 46.7 mmol, HPLC RT=2.99 min) in methanol (250 mL) at 0° C. was bubbled HCl gas.
The reaction was allowed to warm to room temperature and stirred overnight.
The reaction mixture was concentrated in vacuo to give an orange oil, which was purified by flash chromatography using hexanes as eluant to give methyl 2-bromo-5-chlorobenzoate as a colorless oil (10.7 g, 92percent yield). TLC Rf=0.6 (5percent EtOAc-hexanes); HPLC RT=3.48 min, method A; 1H NMR (CDCl3, 400 MHz) 7.78 ppm (d, 1H, J=2.6 Hz); 7.59 ppm (d, 1H, J=12.81 Hz);7.30 ppm (dd, 1H, J=8.6,2.5 Hz); 3.94 ppm (s, 3H).
Reference: [1] Patent: US2003/13700, 2003, A1,
[2] Patent: US6528503, 2003, B2,
[3] Patent: US2002/119992, 2002, A1,
  • 4
  • [ 67-56-1 ]
  • [ 21739-93-5 ]
  • [ 27007-53-0 ]
YieldReaction ConditionsOperation in experiment
4.17 g for 3 h; Reflux 2-bromo-5-chlorobenzoic acid (4g, 0.Ol6mol) was dissolved in MeOH (20m1) and sulphuric acid (imI) was added. The reaction was refluxed for 3h then cooled at RT. Water (20m1) was added and the solid was filtered, dissolved in DCM and washed with saturated aqueous solution of NaHCO3. The organic solvent was dried (Na2SO4) and evaporated to obtain 4.17g of the title compound as oil.1HNMR (CDCl3) 5 ppm= 7.81(d,1H), 7.61(d,1H),7.33(dd,1H), 3.96 (s,3H).
4.17 g for 3 h; Reflux 2-bromo-5-chlorobenzoic acid (4 g, 0.016 mol) was dissolved in MeOH (20 ml) and sulphuric acid (1 ml) was added. The reaction was refluxed for 3 h then cooled at RT. Water (20 ml) was added and the solid was filtered, dissolved in DCM and washed with saturated aqueous solution of NaHCO3. The organic solvent was dried (Na2SO4) and evaporated to obtain 4.17 g of the title compound as oil. 1HNMR (CDCl3) δ ppm=7.81 (d, 1H), 7.61 (d, 1H), 7.33 (dd, 1H), 3.96 (s, 3H).
4.17 g for 3 h; Reflux 2-bromo-5-chlorobenzoic acid (4 g, 0.016 mol) was dissolved in MeOH (20 ml) and sulphuric acid (1 ml) was added. The reaction was refluxed for 3 h then cooled at RT. Water (20 ml) was added and the solid was filtered, dissolved in DCM and washed with saturated aqueous solution of NaHCO3. The organic solvent was dried (Na2SO4) and evaporated to obtain 4.17 g of the title compound as oil. 1HNMR (CDCl3) δ ppm=7.81 (d, 1H), 7.61 (d, 1H), 7.33 (dd, 1H), 3.96 (s, 3H).
Reference: [1] Antimicrobial Agents and Chemotherapy, 2016, vol. 60, # 7, p. 3980 - 3987
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 20, p. 3477 - 3482
[3] Patent: WO2010/53210, 2010, A1, . Location in patent: Page/Page column 34
[4] Patent: WO2013/92893, 2013, A1, . Location in patent: Page/Page column 34; 35
[5] Patent: WO2013/127913, 2013, A1, . Location in patent: Page/Page column 50; 51
[6] Patent: WO2014/25658, 2014, A1, . Location in patent: Page/Page column 24
[7] Patent: US2014/357653, 2014, A1, . Location in patent: Paragraph 0185; 0186; 0187
[8] Patent: US2015/51226, 2015, A1, . Location in patent: Paragraph 0271; 0272; 0273
[9] Tetrahedron, 2016, vol. 72, # 24, p. 3454 - 3467
[10] Organic and Biomolecular Chemistry, 2017, vol. 15, # 22, p. 4831 - 4841
[11] Patent: WO2017/139603, 2017, A1, . Location in patent: Page/Page column 112
[12] Organic Letters, 2018, vol. 20, # 5, p. 1316 - 1319
  • 5
  • [ 79-37-8 ]
  • [ 21739-93-5 ]
  • [ 27007-53-0 ]
Reference: [1] Patent: US2003/153570, 2003, A1,
  • 6
  • [ 21739-93-5 ]
  • [ 18107-18-1 ]
  • [ 27007-53-0 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 14, p. 3878 - 3882[2] Angew. Chem., 2013, vol. 125, # 14, p. 4132
[3] Organic Letters, 2016, vol. 18, # 13, p. 3102 - 3105
  • 7
  • [ 21739-93-5 ]
  • [ 77-78-1 ]
  • [ 27007-53-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 20, p. 7232 - 7246
  • 8
  • [ 56961-26-3 ]
  • [ 21739-93-5 ]
Reference: [1] Patent: US2002/193398, 2002, A1,
[2] Patent: US2002/119992, 2002, A1,
  • 9
  • [ 106-39-8 ]
  • [ 124-38-9 ]
  • [ 21739-93-5 ]
  • [ 21739-92-4 ]
Reference: [1] Tetrahedron Letters, 1997, vol. 38, # 9, p. 1559 - 1562
  • 10
  • [ 2516-95-2 ]
  • [ 21739-93-5 ]
Reference: [1] Journal of the Chemical Society, 1904, vol. 85, p. 1269
  • 11
  • [ 14495-51-3 ]
  • [ 21739-93-5 ]
Reference: [1] Journal of the Chemical Society, 1904, vol. 85, p. 1269
  • 12
  • [ 21739-93-5 ]
  • [ 68-12-2 ]
  • [ 4506-45-0 ]
Reference: [1] Tetrahedron Letters, 2018, p. 1564 - 1567
  • 13
  • [ 106-39-8 ]
  • [ 124-38-9 ]
  • [ 21739-93-5 ]
  • [ 21739-92-4 ]
Reference: [1] Tetrahedron Letters, 1997, vol. 38, # 9, p. 1559 - 1562
  • 14
  • [ 21739-93-5 ]
  • [ 75-16-1 ]
  • [ 935-99-9 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 1, p. 80 - 83
  • 15
  • [ 21739-93-5 ]
  • [ 935-99-9 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 29, p. 7509 - 7513[2] Angew. Chem., 2013, vol. 125, # 29, p. 7657 - 7661,5
  • 16
  • [ 21739-93-5 ]
  • [ 439117-38-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 20, p. 3477 - 3482
[2] Patent: WO2014/25658, 2014, A1,
[3] Patent: WO2017/139603, 2017, A1,
[4] Patent: US2002/119992, 2002, A1,
  • 17
  • [ 21739-93-5 ]
  • [ 60666-70-8 ]
YieldReaction ConditionsOperation in experiment
100% at 10 - 20℃; Inert atmosphere Compound 17-2 (0420) Compound 17-1 (5.0 g, 21.23 mmol) was added to BH3/THF (1 M, 85 mL) under nitrogen atmosphere at 10° C. After addition, the mixture was stirred at room temperature overnight, quenched with methanol (30 mL) at 0° C. and concentrated to dryness. The residue was dissolved in methanol (100 mL) and concentrated to dryness again. This operation was repeated twice to afford 17-2 as a white solid (4.7 g, quantitative yield).
98%
Stage #1: With borane-THF In tetrahydrofuran at 0 - 20℃; Inert atmosphere
Stage #2: With hydrogenchloride In tetrahydrofuran; water at 0℃; for 1 h;
B.l. (2-bromo-5-chloro-phenyl)-methanol:Starting from 2-bromo-5-chlorobenzoic acid (158.0 g; commercial) and proceeding in analogy to Procedure I, the title compound was obtained, without additional purification, as a white solid (146.0 g; 98percent yield).1H NMR (d6-DMSO) δ: 7.58 (d, J = 8.5 Hz, 1H); 7.52-7.49 (d, J = 2.8 Hz, 1H); 7.26 (dd, J = 8.5, 2.8 Hz, 1H); 5.56 (t, J = 5.7 Hz, 1H); 4.47 (d, J = 5.7 Hz, 2H). Procedure I (reduction of carboxylic acid):A solution of the acid (1.0 mmol; 1.0 eq.) in dry THF (4 mL), under inert atmosphere (N2), is treated with a solution of borane-THF complex (IM in THF; 1.5 eq.) at 0°C. The reaction mixture is stirred at rt and monitored by LC-MS. Upon reaction completion, the reaction mixture is poured into an aq. 2N HC1 solution at 0°C. It is further stirred at 0°C for 1 h and THF is removed under reduced pressure. The obtained aq. layer is extracted with EA (3x) and the combined org. layers are washed with IN NaOH, water and brine, dried over Na2S04, filtered and concentrated under reduced pressure. Purification of the residue gives the desired product.
88%
Stage #1: With borane-THF In tetrahydrofuran at 0 - 20℃;
Stage #2: With methanol In tetrahydrofuran
To a solution of 2-bromo-5-chlorobenzoic acid (5.49 g, 23.3 mmol) in anhydrous THF (70 mL) under nitrogen was added dropwise a BH3 THF solution (1.0 M, 55 mL) at 0° C. and the reaction mixture was stirred overnight at room temperature. Then the mixture was cooled on an ice bath and MeOH (20 mL) was added dropwise to decompose excess BH3. The resulting mixture was stirred until no bubble was released and then 10percent NaOH (10 mL) was added. The mixture was concentrated and the residue was mixed with water (200 mL) and extracted with EtOAc. The residue from rotary evaporation was purified by silica gel column chromatography (5:1 hexane/EtOAc) to give 2-bromo-5-chlorobenzyl alcohol as a white solid (4.58 g, 88percent): 1H NMR (300 MHz, DMSO-d6): δ (ppm) 7.57 (d, J=8.7 Hz, 1H), 7.50-7.49 (m, 1H), 7.28-7.24 (m, 1H), 5.59 (t, J=6.0 Hz, 1H), 4.46 (d, J=6.0 Hz, 2H).
88% With borane-THF In tetrahydrofuran at 0 - 20℃; To a solution of 2-bromo-5-chlorobenzoic acid (5.49 g, 23.3 mmol) in anhydrous THF (70 mL) under nitrogen was added dropwise a BH3 THF solution (1.0 M, 55 mL) at 0° C. and the reaction mixture was stirred overnight at room temperature.
Then the mixture was cooled on an ice bath and MeOH (20 mL) was added dropwise to decompose excess BH3.
The resulting mixture was stirred until no bubble was released and then 10percent NaOH (10 mL) was added.
The mixture was concentrated and the residue was mixed with water (200 mL) and extracted with EtOAc.
The residue from rotary evaporation was purified by silica gel column chromatography (5:1 hexane/EtOAc) to give 2-bromo-5-chlorobenzyl alcohol as a white solid (4.58 g, 88percent): 1H NMR (300 MHz, DMSO-d6): δ (ppm) 7.57 (d, J=8.7 Hz, 1H), 7.50-7.49 (m, 1H), 7.28-7.24 (m, 1H), 5.59 (t, J=6.0 Hz, 1H), 4.46 (d, J=6.0 Hz, 2H).
23.2 g With borane-THF In tetrahydrofuran at 0 - 20℃; for 16 h; Inert atmosphere Step 1 : Preparation of (2-bromo-5-chloro-phenyl)methanol (A) A solution of borane-tetrahydrofuran complex in THF (0.15 L, 1.5 eq) was added dropwise to a solution of 2-bromo-5-chlorobenzoic acid (24 g) in anhydrous tetrahydrofuran (0.24 L) at 0°C and under argon atmosphere. The reaction mixture was stirred at room temperature for 16 h, before being slowly poured onto 0.10 L of a 2N aqueous solution of hydrogen chloride at 0°C. The mixture was stirred for 15 minutes and the volatiles were removed under reduced pressure. The aqueous layer was extracted with ethyl acetate and the combined organic layers were washed with a IN aqueous solution of sodium hydroxide and then water. After drying over sodium sulfate, filtration and concentration under reduced pressure, the crude product was purified by column chromatography; 23.2 g; M.p. 79-80 °C.
23.48 g With borane-THF In tetrahydrofuran at 0 - 20℃; Inert atmosphere A solution of the acid (1.0 mmol; 1.0 eq.) in dry THF (4 mL) in a round-bottomed flask, under inert atmosphere (N2), is treated with a solution of borane-THF complex (1M in THF; 1.5 eq.) at 0° C. The reaction mixture is stirred at rt and monitored by LC-MS. Upon reaction completion, the reaction mixture is concentrated under reduced pressureand diluted with EA and 1N HCl. The layers are separated and the aq. layer is extracted with EA (3×). The combined org. layers are washed with 1N HCl, 1M NaOH, water and brine, dried over MgSO4, filtered and concentrated under reduced pressure. Purification of the residue gives the desired product.
S.1.
(2-bromo-5-chloro-phenyl)-methanol
Starting from 2-bromo-5-chlorobenzoic acid (25.0 g) and proceeding in analogy to Procedure AF, the title compound was obtained, without additional purification, as a white solid (23.48 g).
1H NMR (d6-DMSO) δ: 7.58 (d, J=8.5 Hz, 1H); 7.52-7.49 (d, J=2.8 Hz, 1H); 7.26 (dd, J=8.5, 2.8 Hz, 1H); 5.56 (t, J=5.7 Hz, 1H); 4.47 (d, J=5.7 Hz, 2H).

Reference: [1] Patent: US9138427, 2015, B2, . Location in patent: Page/Page column 295
[2] Patent: WO2012/131588, 2012, A1, . Location in patent: Page/Page column 96; 108
[3] Chemical Communications, 2018, vol. 54, # 20, p. 2467 - 2470
[4] Journal of Medicinal Chemistry, 2006, vol. 49, # 15, p. 4447 - 4450
[5] Patent: US2007/265226, 2007, A1, . Location in patent: Page/Page column 58
[6] Patent: US2007/286822, 2007, A1, . Location in patent: Page/Page column 59
[7] Patent: US2007/293457, 2007, A1, . Location in patent: Page/Page column 39
[8] Journal of the American Chemical Society, 2011, vol. 133, # 20, p. 7916 - 7925
[9] Patent: WO2011/121555, 2011, A1, . Location in patent: Page/Page column 114-115
[10] Patent: WO2013/50591, 2013, A2, . Location in patent: Page/Page column 36; 37
[11] Patent: US2013/96119, 2013, A1, . Location in patent: Paragraph 0717; 0838; 0839
[12] Organic Letters, 2018, vol. 20, # 11, p. 3310 - 3313
[13] Patent: US2007/286822, 2007, A1, . Location in patent: Page/Page column 42-43
  • 18
  • [ 21739-93-5 ]
  • [ 124-63-0 ]
  • [ 57381-37-0 ]
Reference: [1] Patent: US5130318, 1992, A,
  • 19
  • [ 21739-93-5 ]
  • [ 174265-12-4 ]
Reference: [1] Journal of the American Chemical Society, 2011, vol. 133, # 20, p. 7916 - 7925
[2] Chemical Communications, 2018, vol. 54, # 20, p. 2467 - 2470
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 21739-93-5 ]

Aryls

Chemical Structure| 93224-85-2

[ 93224-85-2 ]

2-Bromo-6-chlorobenzoic acid

Similarity: 0.94

Chemical Structure| 57381-62-1

[ 57381-62-1 ]

Methyl 2-bromo-4-chlorobenzoate

Similarity: 0.91

Chemical Structure| 42860-02-6

[ 42860-02-6 ]

3-Bromo-5-chlorobenzoic acid

Similarity: 0.88

Chemical Structure| 42860-10-6

[ 42860-10-6 ]

3-Bromo-4-chlorobenzoic acid

Similarity: 0.88

Chemical Structure| 936-08-3

[ 936-08-3 ]

2-Bromo-4-chlorobenzoic acid

Similarity: 0.87

Bromides

Chemical Structure| 93224-85-2

[ 93224-85-2 ]

2-Bromo-6-chlorobenzoic acid

Similarity: 0.94

Chemical Structure| 57381-62-1

[ 57381-62-1 ]

Methyl 2-bromo-4-chlorobenzoate

Similarity: 0.91

Chemical Structure| 42860-02-6

[ 42860-02-6 ]

3-Bromo-5-chlorobenzoic acid

Similarity: 0.88

Chemical Structure| 42860-10-6

[ 42860-10-6 ]

3-Bromo-4-chlorobenzoic acid

Similarity: 0.88

Chemical Structure| 936-08-3

[ 936-08-3 ]

2-Bromo-4-chlorobenzoic acid

Similarity: 0.87

Chlorides

Chemical Structure| 93224-85-2

[ 93224-85-2 ]

2-Bromo-6-chlorobenzoic acid

Similarity: 0.94

Chemical Structure| 57381-62-1

[ 57381-62-1 ]

Methyl 2-bromo-4-chlorobenzoate

Similarity: 0.91

Chemical Structure| 42860-02-6

[ 42860-02-6 ]

3-Bromo-5-chlorobenzoic acid

Similarity: 0.88

Chemical Structure| 42860-10-6

[ 42860-10-6 ]

3-Bromo-4-chlorobenzoic acid

Similarity: 0.88

Chemical Structure| 936-08-3

[ 936-08-3 ]

2-Bromo-4-chlorobenzoic acid

Similarity: 0.87

Carboxylic Acids

Chemical Structure| 93224-85-2

[ 93224-85-2 ]

2-Bromo-6-chlorobenzoic acid

Similarity: 0.94

Chemical Structure| 42860-02-6

[ 42860-02-6 ]

3-Bromo-5-chlorobenzoic acid

Similarity: 0.88

Chemical Structure| 42860-10-6

[ 42860-10-6 ]

3-Bromo-4-chlorobenzoic acid

Similarity: 0.88

Chemical Structure| 936-08-3

[ 936-08-3 ]

2-Bromo-4-chlorobenzoic acid

Similarity: 0.87

Chemical Structure| 25118-59-6

[ 25118-59-6 ]

4-Bromo-3-chlorobenzoic acid

Similarity: 0.85